DE69021294D1 - Furanderivate. - Google Patents

Furanderivate.

Info

Publication number
DE69021294D1
DE69021294D1 DE69021294T DE69021294T DE69021294D1 DE 69021294 D1 DE69021294 D1 DE 69021294D1 DE 69021294 T DE69021294 T DE 69021294T DE 69021294 T DE69021294 T DE 69021294T DE 69021294 D1 DE69021294 D1 DE 69021294D1
Authority
DE
Germany
Prior art keywords
furan derivatives
gastrointestinal
enterokinetic
expected
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69021294T
Other languages
English (en)
Other versions
DE69021294T2 (de
Inventor
Setsuya Sasho
Shunji Ichikawa
Hiromasa Kato
Hiroyuki Obase
Katsuichi Shuto
Yoshimasa Oiji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of DE69021294D1 publication Critical patent/DE69021294D1/de
Publication of DE69021294T2 publication Critical patent/DE69021294T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
DE69021294T 1989-08-17 1990-08-16 Furanderivate. Expired - Fee Related DE69021294T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21192089 1989-08-17

Publications (2)

Publication Number Publication Date
DE69021294D1 true DE69021294D1 (de) 1995-09-07
DE69021294T2 DE69021294T2 (de) 1996-01-25

Family

ID=16613857

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69021294T Expired - Fee Related DE69021294T2 (de) 1989-08-17 1990-08-16 Furanderivate.

Country Status (10)

Country Link
US (1) US5075301A (de)
EP (1) EP0413343B1 (de)
JP (1) JPH0730064B2 (de)
AT (1) ATE125805T1 (de)
CA (1) CA2023311C (de)
DE (1) DE69021294T2 (de)
DK (1) DK0413343T3 (de)
ES (1) ES2075098T3 (de)
GR (1) GR3017870T3 (de)
HK (1) HK1006459A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride
AU662454B2 (en) * 1992-05-12 1995-08-31 Zeria Pharmaceutical Co., Ltd. Novel quaternary ammonium salts and use thereof as medicine
EP0870765B1 (de) * 1995-05-18 2003-11-19 Zeria Pharmaceutical Co., Ltd. Aminothiazolderivate, sie enthaltende arzneimittel und zwischenprodukte in der herstellung dieser verbindungen
CA2269531C (en) * 1996-10-24 2006-03-14 Zeria Pharmaceutical Co., Ltd. Substituted benzoylaminothiazole derivatives and drugs containing the same
US6152966A (en) * 1998-05-13 2000-11-28 Novo Nordisk A/S Treatment of cork with a phenol oxidizing enzyme
WO2000027805A1 (en) 1998-11-05 2000-05-18 Novo Nordisk A/S Substituted 3,3-diamino-2-propenenitriles, their preparation and use
US6362205B2 (en) 1998-11-05 2002-03-26 Novo Nordisk A/S Substituted 3,3-diamino-2-propenenitriles, their preparation and use
EP1689231A4 (de) * 2003-12-04 2007-11-14 Bayer Cropscience Ag Insektizide n-(heteroarylalkyl)alkandiamin-derivate
CN111303087B (zh) * 2020-04-07 2021-08-10 自然资源部第三海洋研究所 呋喃酮类化合物及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048058A (en) * 1975-08-13 1977-09-13 Standard Oil Company (Indiana) Methods to be used in reforming processes employing multi-metallic catalysts
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FI832520L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4458077A (en) * 1982-11-22 1984-07-03 American Home Products Corporation Heterocyclic anti-ulcer agents
GB2209163B (en) * 1987-08-28 1991-04-24 Toyama Chemical Co Ltd Amine derivative and its salt, process for producing the same, and anti-ulcer agent containing the same

Also Published As

Publication number Publication date
ES2075098T3 (es) 1995-10-01
JPH03163074A (ja) 1991-07-15
US5075301A (en) 1991-12-24
DE69021294T2 (de) 1996-01-25
EP0413343A2 (de) 1991-02-20
DK0413343T3 (da) 1995-12-11
ATE125805T1 (de) 1995-08-15
EP0413343B1 (de) 1995-08-02
CA2023311C (en) 1999-11-02
JPH0730064B2 (ja) 1995-04-05
HK1006459A1 (en) 1999-02-26
GR3017870T3 (en) 1996-01-31
CA2023311A1 (en) 1991-02-18
EP0413343A3 (en) 1992-04-22

Similar Documents

Publication Publication Date Title
LU90829I2 (fr) Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
LU90219I2 (fr) Tolcapone et ses dérivés pharmaceutiquement acceptables (TASMAR)
LU91039I2 (fr) Proteq flu et ses dérivés pharmaceutiquement acceptables
LV10442A (lv) Panemiens pirimidina atvasinajumu iegusanai
KR870700602A (ko) 메바로노락톤 및 그것의 유도체의 헤테로사이클릭 유사체 및 그것의 생산방법 및 약학적인 그것의 용도
LU90484I2 (fr) Novorapid - insuline asparte et ses sels et derives pharmaceutiquement acceptables
DK351789A (da) Furanderivater
LU88790I2 (fr) Moxidectin et ses dérivés pharmaceutiquement acceptables
ATE125805T1 (de) Furanderivate.
KR910700046A (ko) 포르피린의 생산 및 용도
LU88843I2 (fr) Ropivacaine et ses dérivés pharmaceutiquement acceptables (Naropine R)
LV10436A (lv) Azola atvasinajumi un to iegusanas starpprodukti
LV10074A (lv) Aizvietoti bicikloheptadiona atvasinajumi un to iegusanas panemiens un herbicidi
IT8822760A0 (it) Ciclodestrinclatrati di derivati della 5-ciano-prostaciclina e loro impiego come medicinali
JPS5419959A (en) Novel daunobicine derivative * production thereof and use of same as drug
SE7902915L (sv) 4-oxo-4h-pyrido(1,2-a)pyrimidin-3-n-(1h-tetrazol-5-yl) karboxamidderivat och deras anvendning sasom inhibitorer av allergiska reaktioner
DK329189A (da) Glycerolderivat og dets farmakologiske anvendelse
LU90110I2 (fr) Penciclovir et ses dérivés pharmaceutiquement acceptables
DK283586A (da) Penemderivater
KR900700484A (ko) 1,4:3,6-디안히드로 헥시톨 잘산염의 아미노프로판올 유도체,그의 제법 및 약제로서의 그의 용도
KR920007626A (ko) 벤조[b]티오펜-2-카르복시이미드아미드 유도체의 사용방법
FR2345152A1 (fr) Nouveaux derives 4-substitues d'acides et d'esters pyrazolo-(1,5-a)quinoxaline-3-carboxyliques
IT1095602B (it) Derivati d'acidi furoil-o tenoil-naftilossialchil-carbossilio i,loro preparazione e loro impiego come medicamenti
BE851997A (fr) Ergosine et ses sels d'addition d'acides physiologiquement acceptables
DE69018903D1 (de) Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee